193 related articles for article (PubMed ID: 21092281)
1. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression.
Baydoun HH; Pancewicz J; Bai X; Nicot C
Mol Cancer; 2010 Nov; 9():302. PubMed ID: 21092281
[TBL] [Abstract][Full Text] [Related]
2. Cyclin E-CDK2 protein phosphorylates plant homeodomain finger protein 8 (PHF8) and regulates its function in the cell cycle.
Sun L; Huang Y; Wei Q; Tong X; Cai R; Nalepa G; Ye X
J Biol Chem; 2015 Feb; 290(7):4075-85. PubMed ID: 25548279
[TBL] [Abstract][Full Text] [Related]
3. The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles.
Xie R; Medina R; Zhang Y; Hussain S; Colby J; Ghule P; Sundararajan S; Keeler M; Liu LJ; van der Deen M; Mitra P; Lian JB; Rivera-Perez JA; Jones SN; Stein JL; van Wijnen AJ; Stein GS
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12359-64. PubMed ID: 19590016
[TBL] [Abstract][Full Text] [Related]
4. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
5. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.
Romeo MM; Ko B; Kim J; Brady R; Heatley HC; He J; Harrod CK; Barnett B; Ratner L; Lairmore MD; Martinez E; Lüscher B; Robson CN; Henriksson M; Harrod R
Virology; 2015 Feb; 476():271-288. PubMed ID: 25569455
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation.
Liu Q; Liu X; Gao J; Shi X; Hu X; Wang S; Luo Y
Int J Biol Sci; 2013; 9(6):541-9. PubMed ID: 23781148
[TBL] [Abstract][Full Text] [Related]
10. Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.
Doueiri R; Anupam R; Kvaratskhelia M; Green KB; Lairmore MD; Green PL
Retrovirology; 2012 Aug; 9():64. PubMed ID: 22876852
[TBL] [Abstract][Full Text] [Related]
11. p30 protein: a critical regulator of HTLV-1 viral latency and host immunity.
Moles R; Sarkis S; Galli V; Omsland M; Purcell DFJ; Yurick D; Khoury G; Pise-Masison CA; Franchini G
Retrovirology; 2019 Dec; 16(1):42. PubMed ID: 31852501
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of MCM3 protein by cyclin E/cyclin-dependent kinase 2 (Cdk2) regulates its function in cell cycle.
Li J; Deng M; Wei Q; Liu T; Tong X; Ye X
J Biol Chem; 2011 Nov; 286(46):39776-85. PubMed ID: 21965652
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.
de La Fuente C; Santiago F; Chong SY; Deng L; Mayhood T; Fu P; Stein D; Denny T; Coffman F; Azimi N; Mahieux R; Kashanchi F
J Virol; 2000 Aug; 74(16):7270-83. PubMed ID: 10906181
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.
Wang L; Deng L; Wu K; de la Fuente C; Wang D; Kehn K; Maddukuri A; Baylor S; Santiago F; Agbottah E; Trigon S; Morange M; Mahieux R; Kashanchi F
Mol Cell Biochem; 2002 Aug; 237(1-2):137-53. PubMed ID: 12236581
[TBL] [Abstract][Full Text] [Related]
15. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.
Yamamoto B; Li M; Kesic M; Younis I; Lairmore MD; Green PL
Retrovirology; 2008 May; 5():38. PubMed ID: 18474092
[TBL] [Abstract][Full Text] [Related]
16. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
Datta A; Silverman L; Phipps AJ; Hiraragi H; Ratner L; Lairmore MD
Retrovirology; 2007 Jul; 4():49. PubMed ID: 17634129
[TBL] [Abstract][Full Text] [Related]
17. The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.
Willmer T; Peres J; Mowla S; Abrahams A; Prince S
Cell Cycle; 2015; 14(19):3173-83. PubMed ID: 26266831
[TBL] [Abstract][Full Text] [Related]
18. The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30
Hutchison T; Malu A; Yapindi L; Bergeson R; Peck K; Romeo M; Harrod C; Pope J; Smitherman L; Gwinn W; Ratner L; Yates C; Harrod R
Virology; 2018 Jul; 520():39-58. PubMed ID: 29777913
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
[TBL] [Abstract][Full Text] [Related]
20. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells.
Lunn CL; Chrivia JC; Baldassare JJ
Cell Cycle; 2010 Nov; 9(22):4533-41. PubMed ID: 21088490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
